Delivery Order SPE2DB20D3101-SPE2DB23FRXE4
Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $158
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $65,000 firm fixed price delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The order is associated with DLA's pharmaceutical prime vendor contract and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late July 2023. No subcontractors or set aside designations were indicated. This order supports...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $64,860 delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by September 8, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is placed against an existing DLA-managed contract vehicle. Amerisourcebergen will...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $326,080 firm fixed price delivery order by the Defense Logistics Agency to provide Buprenorphine 15 mcg/hr patches. The order is to be fulfilled on June 28-29, 2023 with place of performance in Conshohocken, Pennsylvania. The Defense Logistics Agency's order is likely placed against their Pharmaceutical Prime Vendor contract, which establishes Amerisourcebergen as a primary supplier of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $852.58 firm fixed price delivery order by the Defense Logistics Agency to provide 4562086970 Buprenorphine 15 mcg/hr patches for the period of September 7-8, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. This delivery order was issued under an existing DLA...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $53,860 delivery order by the Defense Logistics Agency to provide Buprenorphine 10 mcg/hr patches. The firm fixed price order is for a one-day period of performance in Conshohocken, Pennsylvania under the DLA's pharmaceutical products and services contract vehicle. As the prime contractor, Amerisourcebergen will deliver the opioid addiction treatment patches without involving major subcontractors....
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $296,760 delivery order by the Defense Logistics Agency to provide Buprenorphine 20 mcg/hr patches. The firm fixed price contract runs from September 1-5, 2023 and calls for the patches to be delivered to a location in Conshohocken, Pennsylvania. As the DLA handles procurement for the Department of Defense, these patches will likely be used to support treatment programs for opioid use disorder...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $64,860 firm fixed price delivery order by the Defense Logistics Agency to provide Buprenorphine 5 mcg/hr patches. The order is being fulfilled under DLA's pharmaceuticals and medical/surgical supply schedule, and performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 28-29, 2023. As the prime contractor, Amerisourcebergen will deliver the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,143.50 to supply Buprenorphine 7.5 mcg/hr patches. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to the stated place of performance in Conshohocken, Pennsylvania by the completion date of October 27, 2023. No set-aside designation was applied to this award issued against an existing indefinite delivery contract held...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $57,970 delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to provide buprenorphine 5 mcg/hr patches. The firm fixed price order requires delivery to a location in Conshohocken, Pennsylvania within a one day period beginning on September 7, 2023. The Defense Logistics Agency will utilize these transdermal patches to support treatment programs for opioid...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $239,000 firm fixed price delivery order by the Defense Logistics Agency to provide 4561904076 Buprenorphine 10 mcg/hr patches over a one day period in August 2023. The patches will be delivered to a location in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were indicated. The contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRXE4Delivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $158,000 delivery order by the Defense Logistics Agency to provide Buprenorphine 15 mcg/hr patches. The order is placed against an existing DLA pharmaceuticals contract vehicle and will be fulfilled by Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. No subcontractors or set aside designations were identified. This order supports the DLA's mission to provide pharmaceuticals and other medical supplies to the U.S. military and is consistent with the agency's role in bulk purchasing of such products for distribution to military treatment facilities.
Generated 12/18/23, 11:46 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $158 | 9/11/23 |